SIGA Technologies Inc (SIGA)
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market in the United States. Its lead product is TPOXX, an antiviral medicine used in the treatment of human smallpox disease caused by the variola virus. The company was incorporated in 1995 and is headquartered in New York, New York. SIGA Technologies common stock is listed on NASDAQ under the ticker SIGA.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-SIGA
|
$3.35
|
6.8% Upside
|
Fair
|
Not available
|
Not available
|
Fair
|
39.3%
|
November 5, 2026
|
1.3x
|
4.1x
|
225.6 M
|
102 M
|
0.2%
|
57.2%
|
13.0
|
0.8%
|
735.5%
|
